SCHEMBL20176512

SCHEMBL20176512

c1ccc(-c2ccc(-c3c4ccccc4c(-c4ccc(-c5ccc6c7c8ccccc8ccc7n(-c7ccccc7)c6c5)nc4)c4ccccc34)cc2)cc1

nearest known ligand 0.33

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PTGES O14684 2/20 0.32
JAK2 O60674 1/20 0.31
JAK3 P52333 1/20 0.31
MAPT P10636 2/20 0.31
ALDH1A1 P00352 2/20 0.31
KMT2A Q03164 2/20 0.31
MEN1 O00255 1/20 0.31
HSP90AA1 P07900 1/20 0.31
TSHR P16473 1/20 0.31
CYP2C19 P33261 1/20 0.31
HSD17B1 P14061 1/20 0.30
HSD17B2 P37059 1/20 0.30
AVPR1A P37288 1/20 0.30
ESR1 P03372 1/20 0.30
ESR2 Q92731 1/20 0.30
KDM4E B2RXH2 2/20 0.30
CYP11B1 P15538 1/20 0.30
CYP11B2 P19099 1/20 0.30
HPGD P15428 1/20 0.30
ATM Q13315 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL26160965 0.99 PTGES (0.32) PTGESJAK2JAK3MAPTALDH1A1
SCHEMBL26161232 0.94 PTGES (0.31) PTGESMAPTALDH1A1KMT2AMEN1
SCHEMBL26161050 0.93 KHK (0.32) PTGESMAPTALDH1A1KMT2ATSHR
SCHEMBL26161136 0.93 JAK2 (0.36) PTGESJAK2JAK3MAPTALDH1A1
SCHEMBL26160966 0.91 JAK2 (0.37) PTGESJAK2JAK3MAPTALDH1A1
SCHEMBL20176510 0.89 PTGES (0.33) PTGESJAK2JAK3MAPTALDH1A1
SCHEMBL26160969 0.89 PTGES (0.33) PTGESJAK2JAK3MAPTALDH1A1
SCHEMBL19103060 0.88 KDM4E (0.39) JAK2JAK3MAPTALDH1A1KMT2A
SCHEMBL20176495 0.86 HSD17B1 (0.33) MAPTALDH1A1KMT2AMEN1HSP90AA1
SCHEMBL26161236 0.86 JAK2 (0.34) PTGESJAK2JAK3MAPTALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11667622-B2 Organic light emitting compound and organic electroluminescence device using same SOLUS ADVANCED MATERIALS CO., LTD. (KR) 2023-06-06 US disclosed
US-11667622-B2 Organic light emitting compound and organic electroluminescence device using same SOLUS ADVANCED MATERIALS CO., LTD. (KR) 2023-06-06 US disclosed
WO-2018093231-A1 ORGANIC LIGHT EMITTING COMPOUND AND ORGANIC ELECTROLUMINESCENCE DEVICE USING SAME 주식회사 두산 2018-05-24 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11667622-B2 Organic light emitting compound and organic electroluminescence device using same OR10J3, ICMT, SLCO4C1 PTGES 1627/4885JAK2 3546/4885JAK3 3390/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.